Altimmune, Inc. Archives - PeptideBlog

Altimmune, Inc.

Altimmune, Inc.

1 registered trial on this site, 0 active. This page lists the trials this organization is registered as lead sponsor of, for the compounds covered on PeptideBlog.net. It is a registry listing, not an assessment of the company or its products.

Compounds covered

Registered trials

TrialCompoundPhaseStatusSponsorEnrolledPrimary completionRegistry updated
RECLAIM STUDY: Phase 2 Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight
NCT06987513
PemvidutidePhase 2CompletedAltimmune, Inc.100Jul 30, 2026Jul 31, 2026

Data: ClinicalTrials.gov, U.S. National Library of Medicine. See the full trial tracker.